Adolescence is already a busy biological renovation project. Hormones are changing, the brain is still developing, sleep schedules are negotiating with midnight, and the immune system is encountering new infections. Researchers are now investigating whether certain serious infections during this period may also influence the risk of developing multiple sclerosis later in life.
The strongest evidence involves Epstein–Barr virus, or EBV, particularly when infection causes infectious mononucleosis during the teenage years. Other hospital-treated infections have also been associated with a modest increase in later MS diagnoses. However, association is not the same as destiny. Most teenagers who have mono, pneumonia, or another significant infection never develop multiple sclerosis.
Understanding the difference between a risk factor and a direct cause is essential. The immune system is not a courtroom with one dramatic piece of evidence. It is more like a crowded committee meeting in which genes, viruses, hormones, lifestyle, and environmental exposures all interrupt one another.
What Is Multiple Sclerosis?
Multiple sclerosis, commonly abbreviated as MS, is a chronic immune-mediated disease affecting the central nervous system. That system includes the brain, spinal cord, and optic nerves.
In MS, immune activity damages myelin, the protective material surrounding nerve fibers. Myelin works somewhat like insulation around an electrical wire. When it becomes inflamed or damaged, messages traveling between the brain and the rest of the body may slow down, become distorted, or fail to arrive.
The damaged areas may form lesions or scar-like plaques. Depending on their location, a person may experience blurred vision, eye pain, numbness, weakness, balance problems, muscle stiffness, fatigue, bladder difficulties, or changes in memory and concentration. Symptoms vary widely, which is one reason MS can be difficult to recognize.
MS is not contagious, and it is not inherited through a single gene. Researchers believe it develops when an environmentally triggered immune response occurs in someone with underlying biological susceptibility.
Why Are Researchers Focusing on Adolescence?
Environmental exposures do not necessarily have the same effect at every age. Adolescence may represent a sensitive window because the immune system, hormonal system, and nervous system are all undergoing significant changes.
The brain also continues to mature during the teenage years. Myelination, synaptic remodeling, and changes in immune regulation may affect how the body responds to a powerful infection. Scientists are studying whether intense immune activation during this period can leave a lasting biological imprint in susceptible individuals.
This does not mean that the normal teenage immune system is defective. It means timing may influence how genetic susceptibility and environmental exposures interact. The same infection contracted at age seven may not produce exactly the same immune response as it does at age seventeen.
What the Large Swedish Infection Study Found
A population study followed more than 2.4 million people born in Sweden between 1970 and 1994. Researchers examined hospital-diagnosed infections occurring before age 20 and later diagnoses of multiple sclerosis.
Infections occurring from birth through age 10 were not associated with an increased MS diagnosis rate. In contrast, having any hospital-diagnosed infection between ages 11 and 19 was associated with a 33% higher relative rate of a subsequent MS diagnosis.
After researchers excluded infectious mononucleosis, pneumonia, and central nervous system infections, the association became smaller but remained statistically significant, at approximately 17%.
Central nervous system infections during adolescence showed a stronger association, although these cases were relatively uncommon. Respiratory infections were also associated with later MS, but much of that statistical signal disappeared when mononucleosis and pneumonia were excluded.
These findings apply to infections serious enough to receive a hospital diagnosis. They should not be interpreted as evidence that every cold, sore throat, or stomach bug increases MS risk.
Epstein–Barr Virus, Mononucleosis, and MS
Epstein–Barr virus is among the most common human viruses. It spreads primarily through saliva and is often acquired during childhood without causing obvious symptoms. When a first EBV infection occurs during adolescence or young adulthood, it is more likely to produce infectious mononucleosis.
Mono commonly causes extreme fatigue, fever, sore throat, swollen lymph nodes, and sometimes an enlarged spleen. Most people recover within several weeks, although tiredness may continue longer. After the initial infection, EBV remains inactive inside certain cells for life.
Adolescent Mono and the Threefold Association
Another large Swedish study examined nearly 2.5 million people and compared siblings to reduce the influence of shared family genetics and childhood environments.
Hospital-diagnosed infectious mononucleosis between ages 11 and 19 was associated with approximately three times the rate of a later MS diagnosis. The association remained when researchers compared siblings from the same families, suggesting that shared genetic or household factors did not fully explain the finding.
The association was weaker when mononucleosis occurred during early adulthood. This age pattern adds support to the theory that adolescence may be a particularly sensitive period.
The Landmark U.S. Military Study
An influential study analyzed stored blood samples and medical records from more than 10 million young adults serving in the U.S. military. Because blood samples had been collected repeatedly, researchers could determine whether EBV infection occurred before biological signs of multiple sclerosis appeared.
Among people who initially tested negative for EBV, the risk of MS increased approximately 32-fold after they became infected. Similar changes were not detected after infection with other common viruses examined by the researchers.
Levels of neurofilament light chain, a marker of nerve-cell injury, increased after EBV infection rather than before it. This sequence strengthens the case that EBV may be an important upstream event in MS development.
Even so, EBV alone is not sufficient. Roughly nine out of ten adults have evidence of a current or past EBV infection, while only a small minority develop MS. The virus may be a necessary piece of the biological puzzle, but it clearly is not the entire puzzle.
How Could an Infection Contribute to an Autoimmune Disease?
Researchers are investigating several mechanisms. These ideas may overlap rather than compete with one another.
Molecular Mimicry
Molecular mimicry occurs when part of a virus resembles a human protein. The immune system produces antibodies or immune cells to attack the virus, but some of those defenses may mistakenly recognize the body’s own tissue.
Stanford researchers identified antibodies that reacted both to EBNA1, a protein produced by EBV, and to GlialCAM, a protein found in the brain and spinal cord. This cross-reactivity appeared in approximately 20% to 25% of the MS samples examined in several groups.
This mechanism offers a plausible explanation for how an antiviral response could become an attack against nervous-system tissue. It does not appear to explain every case of MS, however.
Long-Lived Infected B Cells
EBV establishes a long-term home inside B cells, immune cells involved in antibody production and immune memory. In genetically susceptible people, infected B cells may behave abnormally, activate other immune cells, or enter areas where they promote chronic inflammation.
The importance of B cells in MS is supported by the effectiveness of several treatments that reduce specific B-cell populations. That observation does not prove that EBV causes every MS lesion, but it gives researchers another biologically credible pathway to investigate.
Inflammation and the Blood-Brain Barrier
A severe infection can cause widespread immune activation. Inflammation may temporarily change the blood-brain barrier, a protective boundary that normally limits which substances and immune cells enter the central nervous system.
Researchers have proposed that intense inflammation could allow autoreactive immune cells to reach nervous-system tissue. A central nervous system infection could theoretically have an even more direct effect. Evidence for this pathway remains less conclusive than the evidence involving EBV.
Do Other Teenage Infections Cause Multiple Sclerosis?
Current research does not justify saying that ordinary teenage infections cause MS. The clearest infection-related evidence concerns EBV, especially symptomatic mononucleosis. Serious bacterial, respiratory, and central nervous system infections have shown associations in observational studies, but those findings require cautious interpretation.
Several explanations are possible. A severe infection might contribute to immune dysregulation. The infection could interact with an existing genetic risk. Early, unrecognized MS-related changes might also make some people more likely to need hospital care, although studies using long delays between infection and diagnosis reduce this concern.
Some infections studied in childhood, including measles, mumps, rubella, chickenpox, pertussis, and scarlet fever, have not consistently been associated with later MS. Therefore, it would be misleading to place every pathogen into one alarming category labeled “future neurological problem.” Biology is complicated enough without giving every head cold a villain costume.
Risk Factors Usually Work Together
Multiple sclerosis probably develops through interactions among numerous risk factors rather than through one isolated exposure. Factors associated with increased susceptibility include certain immune-related genetic variants, having a close relative with MS, smoking, adolescent obesity, low vitamin D status, and EBV infection.
Sex and age also affect population patterns. MS is diagnosed more frequently in women, and symptoms commonly begin in young or middle adulthood. However, pediatric-onset MS can occur, and teenagers with persistent neurological symptoms deserve appropriate evaluation.
Relative risk must also be distinguished from absolute risk. A threefold increase sounds dramatic, but multiplying a relatively uncommon outcome still produces a low probability for most individuals. A teenager who has mononucleosis should recover carefully, follow medical advice, and avoid contact sports while the spleen may be enlargednot spend the next decade expecting MS to appear.
Can Families Reduce the Risk?
There is currently no guaranteed strategy for preventing multiple sclerosis. Families can still support general immune and neurological health without turning daily life into a laboratory experiment.
Reduce Avoidable Infection Exposure
EBV commonly spreads through saliva. Teenagers can reduce exposure by avoiding shared drinks, eating utensils, toothbrushes, and similar personal items. These steps cannot completely prevent transmission because people may spread EBV before realizing they are infected.
Use Recommended Vaccines
Routine vaccination can prevent several serious viral and bacterial diseases. Vaccination has not been shown to eliminate MS risk, but preventing severe infections has substantial benefits independent of MS.
As of July 2026, no FDA-approved vaccine prevents EBV infection. Experimental EBV vaccines and preventive antibodies are being studied, including candidates designed to block viral entry into human cells. Whether an effective EBV vaccine could reduce future MS cases remains an important research question.
Avoid Smoking and Support a Healthy Weight
Smoking and adolescent obesity are both associated with increased MS risk. Supporting smoke-free environments, regular physical activity, adequate sleep, and sustainable nutrition is reasonable for overall health. Discussions about weight should focus on health and support rather than shame, which has never improved anyone’s immune system or family dinner.
Discuss Vitamin D With a Clinician
Low vitamin D levels have been associated with MS susceptibility, but taking excessive supplements can be harmful. A clinician can determine whether testing or supplementation is appropriate based on diet, sun exposure, medical history, and other individual factors.
When Neurological Symptoms Need Medical Attention
Having fatigue after an infection does not automatically suggest MS. Post-infectious tiredness is common, particularly after mononucleosis. Medical evaluation becomes more important when symptoms are focal, persistent, recurrent, or difficult to explain.
Symptoms that warrant prompt professional attention may include:
- Vision loss, blurred vision, or eye pain, especially in one eye
- Persistent numbness or tingling affecting one side or a specific limb
- New weakness, clumsiness, or difficulty walking
- Unexplained balance or coordination problems
- Electric-shock sensations triggered by bending the neck
- New bladder-control problems combined with neurological symptoms
- Symptoms lasting more than 24 hours without another clear explanation
Doctors do not diagnose MS with an EBV antibody test. Because most adults have EBV antibodies, a positive result provides little diagnostic specificity. MS evaluation may involve a neurological examination, magnetic resonance imaging, blood tests to exclude other conditions, spinal-fluid analysis, and sometimes tests measuring nerve-response pathways.
Experiences Related to Adolescent Infection and MS Risk
The following are composite educational scenarios reflecting concerns commonly discussed by patients and families. They are not accounts of specific individuals and should not be treated as diagnostic examples.
Experience One: The Teenager Recovering From Mono
A 16-year-old develops fever, severe fatigue, swollen lymph nodes, and a sore throat. Testing supports infectious mononucleosis. The teenager misses school, temporarily stops sports, and becomes frustrated when energy does not return after a few days.
A parent reads that mono is associated with multiple sclerosis and begins monitoring every headache, dropped pencil, and afternoon nap. The family’s anxiety quickly becomes more disruptive than the infection itself.
The clinician explains that recovery from mono can take weeks and that fatigue may persist longer. The statistical association with MS does not mean the teenager is likely to develop it. The useful plan is straightforward: rest, hydration, follow-up care, avoidance of contact sports until medically cleared, and evaluation of any persistent focal neurological symptoms.
This experience illustrates how population research can be personally frightening when relative risk is presented without absolute context. Scientific awareness should guide sensible observation, not transform normal recovery into a daily neurological exam.
Experience Two: Symptoms Initially Blamed on Stress
A university student remembers having severe mononucleosis at age 15. Several years later, the student develops blurred vision and pain when moving one eye. Because exams are approaching, the symptoms are initially blamed on stress, screen time, and poor sleep.
When the visual problem persists, an eye-care professional identifies signs that may indicate optic neuritis and recommends neurological evaluation. MRI findings and additional testing eventually support an MS diagnosis.
The earlier EBV infection cannot prove why this individual developed MS. It may have been one contributor combined with genetic susceptibility and other environmental factors. More importantly, knowing about the EBV association does not replace the diagnostic process.
The practical lesson is not to assume that every former mono patient has MS. It is to take new, persistent neurological symptoms seriously. Early assessment can shorten the diagnostic journey and allow treatment discussions to begin sooner.
Experience Three: A Family Managing Uncertainty
A teenager has been hospitalized twice for serious respiratory infections. A close relative also has MS, so the family wonders whether the infections have “activated” the disease.
A neurologist explains that hospital-treated adolescent infections have been associated with later MS in large studies, but the increase is modest for infections other than mononucleosis. No clinical test can calculate the teenager’s personal future risk with precision.
The family focuses on actions that are useful regardless of MS: staying current with recommended vaccines, avoiding tobacco exposure, supporting gradual physical recovery, documenting unusual neurological symptoms, and attending regular medical appointments.
They also agree not to interpret ordinary fatigue, muscle soreness, or temporary dizziness as proof of neurological disease. Adolescents experience plenty of mysterious symptoms for reasons ranging from dehydration to growing bodies to the ancient teenage tradition of sleeping four hours before an exam.
This balanced approach respects the research without allowing uncertainty to dominate family life. Risk information is most helpful when it encourages appropriate care and least helpful when it produces constant surveillance of a healthy young person.
What Future Research May Change
Scientists are working to determine whether preventing EBV infection, modifying the immune response to EBV, or targeting EBV-infected B cells can reduce MS risk or disease activity. Vaccine trials are especially important because they may eventually test the relationship more directly.
Researchers also need to identify why almost everyone encounters EBV while only a small fraction develops MS. Better answers may come from combining viral-antibody patterns, genetic markers, immune-cell behavior, lifestyle exposures, and long-term neurological measurements.
Future studies may also clarify whether the apparent effect of adolescence reflects hormonal development, nervous-system maturation, the intensity of mononucleosis, or the age at which EBV establishes persistent infection.
Conclusion
Evidence increasingly supports a relationship between certain serious infections in adolescence and a later diagnosis of multiple sclerosis. The strongest and most consistent association involves Epstein–Barr virus, particularly infectious mononucleosis during the teenage years.
Large studies suggest that adolescence may be a sensitive biological period, while laboratory research offers plausible mechanisms such as molecular mimicry and abnormal activity involving EBV-infected B cells. Nevertheless, an infection is not a diagnosis, and it does not guarantee that MS will develop.
For families, the most useful response is informed rather than alarmed: prevent avoidable infections where possible, follow routine medical guidance, support healthy habits, and seek evaluation for persistent or focal neurological symptoms. Research is steadily connecting more pieces of the puzzle, but it has not turned a history of teenage mono into a crystal ball.
